[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339855-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339855-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","construction-and-evaluation-of-bal-ptx-co-loaded-lipid-nanosystem-for-promoting-anti-lung-cancer-efficacy-of-paclitaxel-and-reducing-chemotherapy-toxicity","Construction and Evaluation of BAL-PTX Co-Loaded Lipid Nanosystem for Promoting the Anti-Lung Cancer Efficacy of Paclitaxel and Reducing the Toxicity of Chemotherapeutic Drugs","","A lipid nanoplatform named BAL-PTX-LN was developed to co-load chiral baicalin derivatives (BAL) and paclitaxel (PTX), aiming to enhance anti-lung cancer efficacy while lowering chemotherapeutic toxicity. The formulation was optimized using central composite design and characterized by TEM, particle size, encapsulation efficiency, hemolysis, release kinetics, stability, and in vivo pharmacokinetics. BAL-PTX-LN showed spherical morphology, high encapsulation efficiency, stability after storage, improved bioavailability and longer half-life, increased apoptosis, reduced IC50, and superior tumor inhibition in nude mice with minimal tissue pathology.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/construction-and-evaluation-of-bal-ptx-co-loaded-lipid-nanosystem-for-promoting-anti-lung-cancer-efficacy-of-paclitaxel-and-reducing-chemotherapy-toxicity/339855/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/construction-and-evaluation-of-bal-ptx-co-loaded-lipid-nanosystem-for-promoting-anti-lung-cancer-efficacy-of-paclitaxel-and-reducing-chemotherapy-toxicity/339855.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is BAL-PTX-LN and what therapeutic goal does it target?","Question",{"text":63,"@type":64},"BAL-PTX-LN is a lipid nanoplatform co-loaded with chiral baicalin derivatives and paclitaxel. It is designed to strengthen paclitaxel’s anti-lung cancer efficacy while reducing chemotherapy toxicity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was BAL-PTX-LN optimized and evaluated experimentally?",{"text":68,"@type":64},"BAL-PTX-LN was optimized using central composite design based on single-factor experiments and evaluated via TEM, particle size, encapsulation efficiency, hemolysis, release kinetics, stability, pharmacokinetics, and in vitro/in vivo antitumor assays, including safety assessment with HE staining.",{"name":70,"@type":61,"acceptedAnswer":71},"What main outcomes demonstrate improved efficacy and safety?",{"text":72,"@type":64},"BAL-PTX-LN achieved spherical morphology with high encapsulation efficiency and long-term stability, showed enhanced PTX bioavailability and half-life, reduced IC50 and increased apoptosis versus PTX alone, and improved tumor inhibition in nude mice. HE staining indicated no pathological tissue changes in the BAL-PTX-LN group, unlike PTX.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339855,1790183661,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","International Journal of Nanomedicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article ORIGINAL RESEARCH  \nConstruction and Evaluation of BAL-PTX  \nCo-Loaded Lipid Nanosystem for Promoting the Anti-Lung Cancer Efficacy of Paclitaxel and Reducing the Toxicity of Chemotherapeutic Drugs  \nTao Chen 1–3 , *, Yumeng Wei 1–3 , *, Suyu Yin 1–3 , *, Wen Li 1–3 , Yuxiang Wang 1–3 , Chao Pi 1–3 , Mingtang Zeng 3 ,4 , Xiaodong Wang 5 , Ligang Chen 6 , Furong Liu 7 , Shaozhi Fu 8 , Ling Zhao2 , 3  \n1Key Laboratory of Medical Electrophysiology, Ministry of Education, School of Pharmacy, Southwest Medical University, Luzhou, 646000, People’s Republic of China; 2Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University; Luzhou, Sichuan, 646000, People’s Republic of China; 3Central Nervous System Drug Key Laboratory of Sichuan Province, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 4Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China; 5Department of Hepatobiliary Diseases, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 6Department of neurosurgery, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 7Department of Oncology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China; 8Department of Oncology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Shaozhi Fu, Department of Oncology, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, People’s Republic of China, Tel +86 830-3165698, Fax +86 830-3165690, Email [shaozhifu513@163.com](shaozhifu513@163.com); Ling Zhao, Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, No. 182, Chunhui Road, Longmatan District, Luzhou, Sichuan, 646000, China, Tel +86 830 2681630, Email [zhaoling@swmu.edu.cn](zhaoling@swmu.edu.cn)  \nPurpose: The present study aimed to develop a lipid nanoplatform, denoted as “BAL-PTX-LN”, co-loaded with chiral baicalin derivatives (BAL) and paclitaxel (PTX) to promote the anti-lung cancer efficacy of paclitaxel and reduce the toxicity of chemotherapeutic drugs.  \nMethods: BAL-PTX-LN was optimized through central composite design based on a single-factor experiments. BAL-PTX-LN was evaluated by TEM, particle size, encapsulation efficiency, hemolysis rate, release kinetics and stability. And was evaluated by pharmacokinetics and the antitumor efficacy studied both in vitro and in vivo. The in vivo safety profile of the formulation was assessed using hematoxylin and eosin (HE) staining.  \nResults: BAL-PTX-LN exhibited spherical morphology with a particle size of 134.36 ± 3.18 nm, PDI of 0.24 ± 0.02, and with an encapsulation efficiency exceeding 90%, BAL-PTX-LN remained stable after 180 days storage. In vitro release studies revealed a zeroorder kinetic model of PTX from the liposomal formulation. No hemolysis was observed in the preparation group. Pharmacokinetic analysis of PTX in the BAL-PTX-LN group revealed an approximately three-fold higher bioavailability and twice longer t 1/2 compared to the bulk drug group. Furthermore, the IC50 of BAL-PTX-LN decreased by 2.35 times (13.48 μg/mL vs 31.722 μg/mL) and the apoptosis rate increased by 1.82 times (29.38% vs 16.13%) at 24 h compared to the PTX group. In tumor-bearing nude mice, the BAL-PTX-LN formulation exhibited a two-fold hi","cbCaiavtGv5rUsk1","https://ap.wps.com/l/cbCaiavtGv5rUsk1","pdf",17050926,23,"English","# Introduction\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is BAL-PTX-LN and what therapeutic goal does it target?\",\"answer\":\"BAL-PTX-LN is a lipid nanoplatform co-loaded with chiral baicalin derivatives and paclitaxel. It is designed to strengthen paclitaxel’s anti-lung cancer efficacy while reducing chemotherapy toxicity.\"},{\"question\":\"How was BAL-PTX-LN optimized and evaluated experimentally?\",\"answer\":\"BAL-PTX-LN was optimized using central composite design based on single-factor experiments and evaluated via TEM, particle size, encapsulation efficiency, hemolysis, release kinetics, stability, pharmacokinetics, and in vitro/in vivo antitumor assays, including safety assessment with HE staining.\"},{\"question\":\"What main outcomes demonstrate improved efficacy and safety?\",\"answer\":\"BAL-PTX-LN achieved spherical morphology with high encapsulation efficiency and long-term stability, showed enhanced PTX bioavailability and half-life, reduced IC50 and increased apoptosis versus PTX alone, and improved tumor inhibition in nude mice. HE staining indicated no pathological tissue changes in the BAL-PTX-LN group, unlike PTX.\"}]","Construction and Evaluation of BAL-PTX Co-Loaded Lipid Nanosystem for Promoting the Anti-Lung Cancer Efficacy of Paclitaxel and Reducing the Toxicity of Chemotherapeutic Drugs | PDF",1790032718,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a2d32835c475bf42ce24af656452133.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6bd9ed9bd486e112ac6309947b3ce33.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9041847a0529afdd2f3c1465794ebb76.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f5013adc941322cad2d20600ef7cfdf.webp",980,1268]